Showing results (41-50 of 365) with videos related to

Sort By:
Pageof 37
Current Opinion in Cardiology|November 21, 1998
Advances in the medical management of acute coronary syndromesC P Cannon
Clinical Cardiology|December 29, 2000
Learning from the recently completed oral glycoprotein IIb/IIIa receptor antagonist trialsC P Cannon
Journal of Internal Medicine|March 8, 2008
Combination therapy in the management of mixed dyslipidaemiaC P Cannon
The American Journal of Cardiology|April 1, 1993
Anticoagulant effects of hirulog, a novel thrombin inhibitor, in patients with coronary artery diseaseC P Cannon, J M Maraganore, J Loscalzo, et al.
The American Journal of Cardiology|August 15, 1996
Distortion of the terminal portion of the QRS on the admission electrocardiogram in acute myocardial infarction and correlation with infarct size and long-term prognosis (Thrombolysis in Myocardial Infarction 4 Trial)Y Birnbaum, R A Kloner, S Sclarovsky, et al.
American Heart Journal|March 1, 1996
Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B InvestigatorsR C Becker, C P Cannon, R P Tracy, et al.
The American Journal of Cardiology|May 15, 1995
Predictors of non-Q-wave acute myocardial infarction in patients with acute ischemic syndromes: an analysis from the Thrombolysis in Myocardial Ischemia (TIMI) III trialsC P Cannon, B Thompson, C H McCabe, et al.
Circulation|May 31, 2001
Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudyC M Gibson, J A de Lemos, S A Murphy, et al.
American Heart Journal|November 14, 1997
Myoglobin, creatine kinase MB, and cardiac troponin-I to assess reperfusion after thrombolysis for acute myocardial infarction: results from TIMI 10AM J Tanasijevic, C P Cannon, D R Wybenga, et al.
Journal of the American College of Cardiology|December 1, 1995
One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarctionH V Anderson, C P Cannon, P H Stone, et al.
Pageof 37